Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 490 results for "ranbaxy laboratories"

DoP rejects Ranbaxy's review petition against fixation of ceil...

The Department of Pharmaceuticals (DoP) has rejected the review application filed by Ranbaxy Laboratories against the fixation/revision of ceiling prices of ciprofloxacin hydrochloride injection 200 mg/100 ml by the National Pharmaceutical Pricing ... PharmaBiz, 3 days ago

6 images for ranbaxy laboratories

India Infoline, 2 weeks ago
Sify, 2 weeks ago
Reuters, 2 weeks ago
First Post.com, 2 weeks ago
Financial Chronicle, 1 month ago
Livemint.com, 1 month ago
Sify

India's Ranbaxy sued in US for manipulating FDA rules

Generic drugmaker Ranbaxy Laboratories Ltd has been sued in a district court in the United States for allegedly manipulating US Food and Drug Administration rules for years to keep rival generic drugs out of the market. Ranbaxy filed "grossly ...
 Business Today India2 weeks ago Ranbaxy sued for manipulating USFDA rules  Times of India2 weeks ago US Class Action Asserts Ranbaxy Manipulated FDA Rules  NDTV Profit2 weeks ago U.S. class action asserts India's Ranbaxy manipulated FDA rules  CNBC2 weeks ago
[x]  

Sun Pharma Falls After Ranbaxy Gets Slapped With Lawsuit

Sun Pharma shares on Friday fell over 2 per cent to Rs 925 after Ranbaxy Laboratories (which it acquired in March) was sued in a district court in the United States for allegedly manipulating US Food and Drug Administration (USFDA) rules for years ...
 NDTV Profit2 weeks ago Sun Pharma drops after listing of shares allotted to Ranbaxy shareholders  Capital Market1 month ago Sun Pharma dips on listing of new shares  Business Standard India1 month ago

Japan's Daiichi Sankyo still on the hook for Ranbaxy bills?

Think Daiichi Sankyo set itself free of Ranbaxy Laboratories when it sold its stock in Sun Pharmaceutical? Think again. It remains possibly liable until 2022 for another $325 million as the Ranbaxy mess is cleaned up in the United States. The ...
 Fierce Drug Delivery2 weeks ago Daiichi Sankyo turned over Ranbaxy's problems to Sun, now cashing in its stake  FiercePharmaManufacturing1 month ago Daiichi Sankyo cashing out after merging Ranbaxy with Sun  FiercePharma1 month ago

Zenotech Labs to be referred to BIFR

The board of directors of Hyderabad-based Zenotech Laboratories Limited, which is now in the hands of Sun Pharmaceutical Industries Limited following the acquisition of Ranbaxy Laboratories by the Indian pharma major, has decided to refer the ...
 Business Standard India3 days ago

Sun Pharma reports Q4 net profit at Rs 888 cr, Ranbaxy deal shrinks earnings

New Delhi: Sun Pharma today reported a consolidated net profit of Rs 888.05 crore for the fourth quarter ended 31 March 2015. The company had posted a net profit of Rs 1,587.12 crore for the same period of the previous fiscal. Net sales of the ...
 Firstpost.com14 hours ago Sun Pharma Q4 Net Down 44% At Rs 888 Crore  Businessworld India13 hours ago Pharmaceutical Newsletter: 27-30 April, 2015  India Infoline4 weeks ago

Sun Pharma net profit dips by 44% in Q4 to Rs.888 cr

Sun Pharmaceutical Industries, a Rs. 27,200 crore plus India's leading pharma company, has posted lower consolidated profit of Rs. 888 crore during the fourth quarter ended March 2015 as compared to Rs. 1,587 crore in the corresponding period of ...
 PharmaBiz16 hours ago Sun Pharma Net Profit Falls 44%  4 Traders16 hours ago Sun Pharma Q4 profit falls 44% to Rs888 crore  Livemint.com16 hours ago
The Telegraph

Merger hurts Sun

Sun Pharmaceutical Industries today reported disappointing numbers for the fourth quarter ended March, mainly because of its merger with Ranbaxy Laboratories and price erosion in some products in the US. The consolidated net profit of the drug major was Rs ...
 The Telegraph8 hours ago

Review and Critique of the MRHA Data Integrity Guidance for Industry — Part 2: Data Governance System

. This is the second of a four-part series reviewing and critiquing the recent Medicines and Healthcare products Regulatory Agency (MHRA) guidance for industry document on data integrity.1 The first part of the series2 provided a background to the ...
 Scientific Computing10 hours ago
First Post.com

Sun Pharmaceuticals loaded with cash and ready to play

If you thought Sun Pharmaceutical Industries would rest on its laurels after buying Ranbaxy Laboratories in India's largest pharma deal, think again. Sun apparently has another $7 billion burning a proverbial hole in its pocket and is looking for ...
 FierceMedicalDevices4 weeks ago Sun Pharma Profit Misses Estimate on Higher Costs, Ranbaxy  Bloomberg16 hours ago Sun Pharma misses profit estimates on Ranbaxy costs | Reuters  NewsR.in10 hours ago India's Sun Pharma misses profit estimates on Ranbaxy costs  Reuters UK13 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less